In the respective report, we have demonstrated that DKK3 methylation was present in 61.3% of breast cancer patients (92 of 150), whereas in 19 matching normal breast tissues only one sample (5.3%) revealed faint methylation signals. The gene discussed is DKK3; the disease is breast carcinoma.